Background Protein structure preprocessing is the foundation of structure-based drug discovery, yet current workflows are highly fragmented. Researchers typically rely on multiple tools such as PyMOL, ChimeraX, and Schrödinger Suite, which leads to complexity, inconsistency, and limited reproducibility. These toolchains often demand advanced expertise in structural biology and computational chemistry, while offering no built-in support for global regulatory requirements (FDA,

Neural Concept: Real-Time Physics Simulation Platform with AI-Based Engineering Intelligence Executive Overview Founded: 2018 (EPFL spinoff) Headquarters: Lausanne, Switzerland (EPFL Innovation Park) Website: https://www.neuralconcept.com Status: Private Company Core Service: 3D Deep Learning-based Engineering Intelligence Platform Total Funding: $38M across 3 rounds Seed: $2M (2020) Series A: $9.1M (March 2022, led by Alven) Series B: $27M (June 2024, led by Forestay Capital

Introduction Challenge in Drug Development: Protein structure preprocessing is a critical step that determines the accuracy of molecular docking and molecular dynamics simulations Experimental structures (X-ray, NMR) contain unnecessary water molecules, crystallization ligands, metal ions, and incomplete hydrogen information Differences from physiological environments reduce reliability for computational studies Limitations of Current Preprocessing: Requires sequential use of

My research paper "Real-time Threat Analysis and Decision Support System for the Korean Peninsula Based on Multi-AI Model Fusion" has been published in the Journal of the Korea Society for Naval Science & Technology on September 30th.  As a Navy reservist, it is deeply meaningful to contribute, even in a small way, to the ROK Navy and national defense. I have invested nearly a year in planning and developing TARGIS BUSAN, continuing to advance it even on holidays and weekends

TraceLink : End-to-End Operations With Real-Time Data for Optimal Business Outcomes Executive Overview Founded:  2009 (originally as SupplyScape in 2003) Headquarters:  Wilmington, Massachusetts, USA (previously North Reading, MA) Website:  https://www.tracelink.com Status:  Private Company Core Service:  Digital network platform for end-to-end pharmaceutical supply chain orchestration Total Funding:  $230M across 8 rounds Annual Revenue:  Estimated $200M+ (2024) Leadership:

CODEXIS CodeEvolver Executive Overview Founded:  2002 Headquarters:  Redwood City, California, USA Website:  https://www.codexis.com...